ZONHONBIO focuses on the deep exploration of the Kallikrein-Kinin System (KKS), an important regulatory system in the body. The KKS system not only regulates endogenous vasodilation but also plays various roles in protecting and restoring endothelial cell integrity and optimal functionality. It plays a significant role in the treatment of central nervous system disorders.

With the aim of developing humanized KKS system gene engineering drugs, ZONHONBIO comprehensively explores the potential application value and drug development potential of each component and their gene engineering derivatives. Positioned as an innovator in central nervous system drugs, we strive to provide more effective treatment options for patients with central nervous system disorders.